Synthesis, Characterization, Computational Analyses, in Silico ADMET Studies, and Inhibitory Action Against SARS-CoV-2 Main Protease (Mpro) of a Schiff Base

Overview

Journal Turk J Chem

Publisher Scientific and Technological Research Council of Turkey

Date 2023 Aug 2

PMID 37529731

Authors

Songul Sahin

Necmi Dege

Affiliations

Soon will be listed here.

Abstract

COVID-19 disease caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2) has struck the whole world and raised severe health, economic, and social problems. Many scientists struggled to find a vaccine or an antiviral drug. Eventually, both vaccines and recommended drugs, repurposed drugs, or drug combinations were found, but new strains of SARS-CoV-2 continue to threaten human life and health. As part of the fight against COVID-19 disease, this study involves an in silico molecular docking analysis on the main protease (Mpro) of SARS-CoV-2. To this aim, a Schiff base compound was synthesized and characterized using spectroscopic techniques, including X-ray, FTIR, and UV-Vis. Surface analysis and electronic properties of this molecule were investigated using the DFT method. The drug-likeness parameters of the title compound were studied according to the rules of Lipinski, Veber, Ghose, Egan, and Muegge and were found in agreement with these rules. In silico toxicity analyses revealed that the new compound is a potentially mutagenic and carcinogenic chemical. The title compound was predicted to be an inhibitor of cytochrome P450 enzymes (5 CYPs). This inhibitory effect indicates a weak metabolism of the molecule in the liver. In addition, this compound was displayed good intestinal absorption and blood-brain barrier penetration. The druggability properties of the title compound were investigated, and SwissTargetPrediction predicted it to be a protease inhibitor. In this context, the SARS-CoV-2 main protease was selected as a biological target in molecular docking studies. Docking results were compared with the known native ligand N3 inhibitor. The value of binding energy between the Schiff base compound and the binding pocket of the main protease is higher than that of the reference ligand N3. The calculated free energies of binding of the Schiff base compound and the reference ligand N3 are -8.10 and -7.11 kcal/mol, respectively.

References

Balachandran V, Karunakaran V . Molecular structure, vibrational spectroscopic, hyperpolarizability, natural bond orbital analysis, frontier molecular orbital analysis and thermodynamic properties of 2,3,4,5,6-pentafluorophenylacetic acid. Spectrochim Acta A Mol Biomol Spectrosc. 2014; 127:473-83. DOI: 10.1016/j.saa.2014.02.129. View

Li X, Wang J, Coutavas E, Shi H, Hao Q, Blobel G . Structure of human Niemann-Pick C1 protein. Proc Natl Acad Sci U S A. 2016; 113(29):8212-7. PMC: 4961162. DOI: 10.1073/pnas.1607795113. View

Lipinski C, Lombardo F, Dominy B, Feeney P . Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001; 46(1-3):3-26. DOI: 10.1016/s0169-409x(00)00129-0. View

Sheldrick G . SHELXT - integrated space-group and crystal-structure determination. Acta Crystallogr A Found Adv. 2014; 71(Pt 1):3-8. PMC: 4283466. DOI: 10.1107/S2053273314026370. View

Sato S . Plasmodium-a brief introduction to the parasites causing human malaria and their basic biology. J Physiol Anthropol. 2021; 40(1):1. PMC: 7792015. DOI: 10.1186/s40101-020-00251-9. View

Sheldrick G . Crystal structure refinement with SHELXL. Acta Crystallogr C Struct Chem. 2015; 71(Pt 1):3-8. PMC: 4294323. DOI: 10.1107/S2053229614024218. View

Xu C, Cheng F, Chen L, Du Z, Li W, Liu G . In silico prediction of chemical Ames mutagenicity. J Chem Inf Model. 2012; 52(11):2840-7. DOI: 10.1021/ci300400a. View

Ghose A, Viswanadhan V, Wendoloski J . A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem. 2000; 1(1):55-68. DOI: 10.1021/cc9800071. View

Jiang S, Shi Z, Shu Y, Song J, Gao G, Tan W . A distinct name is needed for the new coronavirus. Lancet. 2020; 395(10228):949. PMC: 7124603. DOI: 10.1016/S0140-6736(20)30419-0. View

10.

Raineri S, Mellor J . : Linking Metabolism and Epigenetics. Front Genet. 2018; 9:493. PMC: 6206167. DOI: 10.3389/fgene.2018.00493. View

11.

Omar A, Mosa T, El-Sadany S, Hamed E, El-Atawy M . Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study. J Mol Struct. 2021; 1245:131020. PMC: 8255031. DOI: 10.1016/j.molstruc.2021.131020. View

12.

Allen M, Kachadoorian M, Quicksall Z, Zou F, Chai H, Younkin C . Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels. Alzheimers Res Ther. 2014; 6(4):39. PMC: 4198935. DOI: 10.1186/alzrt268. View

13.

Mandal M, Chowdhury S, Khan A, Baildya N, Dutta T, Misra D . Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study. J Mol Struct. 2021; 1234:130152. PMC: 7909904. DOI: 10.1016/j.molstruc.2021.130152. View

14.

Sun L, Song F, Shi N, Liu F, Li S, Li P . Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19. J Clin Virol. 2020; 128:104431. PMC: 7219384. DOI: 10.1016/j.jcv.2020.104431. View

15.

Azhagiri S, Jayakumar S, Gunasekaran S, Srinivasan S . Molecular structure, Mulliken charge, frontier molecular orbital and first hyperpolarizability analysis on 2-nitroaniline and 4-methoxy-2-nitroaniline using density functional theory. Spectrochim Acta A Mol Biomol Spectrosc. 2014; 124:199-202. DOI: 10.1016/j.saa.2013.12.106. View

16.

Swislocka R, Regulska E, Karpinska J, Swiderski G, Lewandowski W . Molecular Structure and Antioxidant Properties of Alkali Metal Salts of Rosmarinic Acid. Experimental and DFT Studies. Molecules. 2019; 24(14). PMC: 6680818. DOI: 10.3390/molecules24142645. View

17.

Kon E, Elia U, Peer D . Principles for designing an optimal mRNA lipid nanoparticle vaccine. Curr Opin Biotechnol. 2021; 73:329-336. PMC: 8547895. DOI: 10.1016/j.copbio.2021.09.016. View

18.

Kumar A, Singh R, Kaur J, Pandey S, Sharma V, Thakur L . Wuhan to World: The COVID-19 Pandemic. Front Cell Infect Microbiol. 2021; 11:596201. PMC: 8042280. DOI: 10.3389/fcimb.2021.596201. View

19.

Rahmani S, Noorolyai S, Ayromlou H, Shahgoli V, Shanehbandi D, Baghbani E . The expression analyses of RMRP, DDX5, and RORC in RRMS patients treated with different drugs versus naïve patients and healthy controls. Gene. 2020; 769:145236. DOI: 10.1016/j.gene.2020.145236. View

20.

Banerjee P, Dunkel M, Kemmler E, Preissner R . SuperCYPsPred-a web server for the prediction of cytochrome activity. Nucleic Acids Res. 2020; 48(W1):W580-W585. PMC: 7319455. DOI: 10.1093/nar/gkaa166. View